FLT4 antibody (Extracellular Domain)
Quick Overview for FLT4 antibody (Extracellular Domain) (ABIN567981)
Target
See all FLT4 AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Binding Specificity
- Extracellular Domain
-
Specificity
- This antibody detects Human VEGFR-3/FLT-4. Other species not tested.
-
Purification
- Affinity Chromatography on Protein G.
-
Immunogen
- Recombinant Human Vascular Endothelial Growth Factor Receptor 3 (rh VEGFR-3/FLT-4) extracellular domain
-
Isotype
- IgG1
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Reconstitution
- Restore in Sterile water to a concentration of 0.1-1.0 mg/mL
-
Concentration
- 0.5 mg/mL
-
Buffer
- PBS, pH 7.4 without preservatives
-
Preservative
- Without preservative
-
Handling Advice
- Avoid repeated freezing and thawing.
-
Storage
- 4 °C/-20 °C
-
Storage Comment
- Prior to reconstitution store at 2-8 °C for 6 month or at -20 °C for longer. Following reconstitution store the antibody undiluted at 2-8 °C for one month.
-
Expiry Date
- 6 months
-
-
- FLT4 (Fms-Related Tyrosine Kinase 4 (FLT4))
-
Alternative Name
- VEGFR-3 / Flt-4
-
Background
- VEGFR-1 (Flt-1), VEGFR-2 (KDR/Flk 1) and VEGFR-3 (FLT-4) belong to the class III subfamily of receptor tyrosine kinases (RTKs). All three receptors contain seven immunoglobulin-like repeats in their extracellular domains and kinase insert domains in their intracellular regions. The expression of VEGFR-1 to -3 is almost exclusively restricted to hematopoietic precursor cells, vascular and lymphatic endothelial cells and to the monocyte/macrophage lineage. These receptors play essential roles in vasculogenesis, hematopoiesis, angiogenesis and lymphangiogenesis. The VEGFR-3 cDNA encodes a 1298 amino acid (aa) residue precursor protein with a 24 aa residue signal peptide. Mature VEGFR-3 is composed of a 751 aa residue extracellular domain, a 22 aa residue transmembrane domain and a 482 aa residue cytoplasmic domain. Both VEGF-C and VEGF-D have been shown to bind and activate VEGF R3 (Flt-4). The Flt-4 gene is widely expressed in the early embryo but becomes restricted to the lymphatic endothelial a latter stage of development. It is important for lymphangiogenesis.Synonyms: FLT4, Tyrosine-protein kinase receptor FLT4, VEGF Receptor 3, VEGFR3, Vascular endothelial growth factor receptor 3
-
Gene ID
- 2324
-
NCBI Accession
- NP_002011
-
UniProt
- P35916
-
Pathways
- RTK Signaling, Signaling Events mediated by VEGFR1 and VEGFR2, VEGF Signaling
Target
-